Edition:
United Kingdom

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

39.98USD
21 Mar 2019
Change (% chg)

-- (--)
Prev Close
$39.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
177,806
52-wk High
$54.45
52-wk Low
$27.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -1.747
Sep '18 0.00 -1.285
Jun '18 0.00 -1.147
Mar '18 0.00 -1.047
FY 2017 Dec '17 0.00 -1.152
Sep '17 0.00 -1.020
Jun '17 0.00 -0.938
Mar '17 0.00 -0.883
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 5 0.00 0.00 0.00 0.00
Quarter Ending Jun-19 5 0.00 0.00 0.00 0.00
Year Ending Dec-19 6 0.00 0.00 0.00 4.47
Year Ending Dec-20 6 22.69 61.20 5.00 59.48
Earnings (per share)
Quarter Ending Mar-19 6 -1.53 -1.45 -1.61 -1.17
Quarter Ending Jun-19 6 -1.55 -1.40 -1.73 -1.26
Year Ending Dec-19 7 -6.13 -5.56 -6.73 -4.20
Year Ending Dec-20 7 -5.35 -4.09 -6.28 -3.36
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.72 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.53 8.39
Price to Book (MRQ) 2.19 10.19 5.27
Price to Tangible Book (MRQ) 2.24 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.74 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -42.39 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago -38.01 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate -- 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 19.38 3.50 2.98
LT Debt to Equity (MRQ) 0.00 19.49 11.35
Total Debt to Equity (MRQ) 0.00 32.17 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.45 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.47 12.43
Operating Margin (TTM) -- -185.04 5.77
Operating Margin - 5 Yr. Avg. -- -126.95 8.02
Pre-Tax Margin (TTM) -- -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.74 8.31
Net Profit Margin (TTM) -- -182.46 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.13 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,655,517 820,307,647
Net Income/Employee (TTM) -1,007,188 513,851 92,854,588
Receivable Turnover (TTM) -- 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.48 6.36 10.60
Return on Assets - 5 Yr. Avg. -- 5.46 11.78
Return on Investment (TTM) -36.94 8.89 13.82
Return on Investment - 5 Yr. Avg. -- 6.77 15.32
Return on Equity (TTM) -37.81 10.00 15.25
Return on Equity - 5 Yr. Avg. -- 8.29 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Atara Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.46 5.69 99 99
13 Week 8.72 3.43 99 95
26 Week -5.26 -12.46 99 98
52 Week -8.06 -22.07 99 71
YTD 14.08 0.19 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 184
Total Shares Held: 50,679,425
3 Mo. Net Change: 1,702,953
# New Positions: 20
# Closed Positions: 19
# Increased Positions: 78
# Reduced Positions: 74
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.